JCRB0425 [HuCCT1]

Profile:Human liver bile duct carcinoma cell line.

Date accepted:01/20/1989
Animal:human
Scientific Name: Homo sapiens
Classification: new
Tissue prepared:liver bile duct
Medium: RPMI1640 medium with 10% fetal bovine serum.
Passage method: Cells treated with 0.05 % trypsin and 0.02 % EDTA for 10 min at 37 C.
CO2 Concentration: 5 %
Cell no. at passage: split ratio= 1/4
Genetics: bile duct carcinoma
Characteristics: bile duct carcinoma
Cell ID data:available
DNA Profile (STR): D5S818:12,13
D13S317:11,13
D7S820:10,11
D16S539:11,12
VWA:18
TH01:7,10
Amelogenin:X,Y
TPOX:8
CSF1PO:11,12
Virus DNA detected: CMV(-), EBV(-), HHV6(-), HHV7(-), BKV(-), JCV(-), ADV(-), parvoB19(-), HBV(-), HTLV1(-), HTLV2(-), HIV1(-), HIV2(-), HPV18(nt) [-/negative, +/positive, nt/not tested] -- Description
Established by Miyagiwa,K. et al.
Deposited bySato,J.,Tokiwa,T.
Cell bank:OUCI(JCRB)
References:(1)

(* The format of the table was revised on Apr.25.2003.)



[ Record(s) of stored ampules ]

[ Lot No.: 022196: seed (JCRB0425) ]

[ Culture condition of this lot.]

[ Additional Data ]

(Date downloaded: 2010-11-22)




Exported from cellroot.dbf and cellspec.dbf.

References

1. Miyagiwa,M., Ichida,T., Tokiwa,T., Sato,J., and Sasaki,H. A new human cholangiocellular carcinoma cell line (HuCCT1) producing carbohydrate antigen 19/9 in serum-free medium, In Vitro Cell Dev. Biol., 25: 503-510, 1989.